all comparisons are cross-study AOD-9604 human safety data / Limited Phase IIb obesity trial (N=536) showed mild, transient adverse events MOTS-c human safety data / Confined to small pilot studies and case series
Moreover, whether you are a cash-paying or insurance patient of the LifeMD GLP-1 program, your insurance may help cover the cost of medication
Head to Toe Changes Semaglutide doesnt target just one body part
Compounding allows for flexible dosing, cost savings, and no insurance hasslebut the medication's efficacy is equivalent to brand medications
That changed at the end of 2025, when the FDA approved the Wegovy pill (oral semaglutide 25 mg), making it the first and only oral GLP-1 medication approved for chronic weight management in adults
they are not transferable to general use